Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,46 USD | +2,10% | +4,29% | -0,68% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2023 | CI |
Métier
Nombre d'employés: 46
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Treatments for Multi-drug Resistant Bacterial Infections
100,0
%
| 54 | 100,0 % | 104 | 100,0 % | +93,95% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 54 | 100,0 % | 104 | 100,0 % | +93,95% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 04/01/21 |
Ankit Mahadevia
FOU | Founder | 43 | 01/04/13 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | 06/11 |
Kamal Hamed
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/09/22 |
Angela Talley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Timothy Keutzer
COO | Chief Operating Officer | 56 | - |
Ted Jenkins
IRC | Investor Relations Contact | - | - |
James P. Brady
HRO | Human Resources Officer | - | - |
Ian A. Critchley
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 01/07/17 |
John Pottage
BRD | Director/Board Member | 71 | 14/08/18 |
Scott Jackson
BRD | Director/Board Member | 60 | 16/04/20 |
Milind Deshpande
FOU | Founder | 68 | 01/01/14 |
Director/Board Member | 61 | 01/09/15 | |
Ankit Mahadevia
FOU | Founder | 43 | 01/04/13 |
Cynthia Smith
BRD | Director/Board Member | 55 | 19/03/19 |
Director/Board Member | 53 | 11/10/21 | |
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 04/01/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 53 892 889 | 42 916 769 ( 79,63 %) | 0 | 79,63 % |
Coordonnées société
Spero Therapeutics, Inc.
675 Massachusetts Avenue 14th floor
02139, Cambridge
+857 242 1600
http://www.sperotherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-0,68% | 78,68 M | |
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |
- Bourse
- Actions
- Action SPRO
- Société Spero Therapeutics, Inc.